Literature DB >> 6113828

The effect of beta-adrenergic blockade on infarct size following experimental coronary occlusion.

K Genth, M Hofmann, M Hofmann, W Schaper.   

Abstract

The effect of Pindolol on myocardial infarct size was studied in 10 open chest dogs. In each animal a sequential occlusion and reperfusion of 2 medium-sized branches of the left coronary artery was performed in the same heart. After occlusion and reperfusion of the control artery the initial dose of Pindolol (0.25 mg/kg body weight) was administered. Thereafter the test artery was occluded, followed by a maintenance dose of Pindolol (0.3 mg/kg body weight). The drug caused a significant decrease in LVP and LV-dp/dt but no change in heart rate. MVO2 also decreased significantly. Regional myocardial blood flow was measured with the tracer microsphere method. Collateral flow in the perfusion area of the control artery was 11.2 +/- 5.9% and in the area of the test artery 10.0 +/- 4.4% of normal. No change in the endo/epi ratio as a result of treatment was observed. The area of infarction (p-nitroblue tetrazolium-reaction) was divided by the area of perfusion (angiography). Infarct size, expressed as the percentage of the perfusion area, was 48.2 +/- 22.2% in the region of the control artery and 43.0 +/- 23.9% in the region of the test artery. The difference was statistically not significant.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6113828     DOI: 10.1007/bf01907953

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  25 in total

Review 1.  Metabolic response during impending myocardial infarction. II. Clinical implications.

Authors:  M F Oliver
Journal:  Circulation       Date:  1972-02       Impact factor: 29.690

2.  Reduction by propranolol of myocardial necrosis following temporary coronary artery occlusion in dogs.

Authors:  K A Reimer; M M Rasmussen; R B Jennings
Journal:  Circ Res       Date:  1973-09       Impact factor: 17.367

3.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

4.  Adrenaline-induced "oxygen-wastage" and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation.

Authors:  L H Opie; F T Thandroyen; C Muller; O L Bricknell
Journal:  J Mol Cell Cardiol       Date:  1979-10       Impact factor: 5.000

5.  Effect of reducing circulating free fatty acids on ventricular arrhythmias during myocardial infarction and on ST-segment depression during exercise-induced ischemia.

Authors:  M F Oliver; M J Rowe; M R Luxton; N E Miller; J M Neilson
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

6.  Effect of ischemia and antianginal drugs on the distribution of radioactive microspheres in the canine left ventricle.

Authors:  L C Becker; N J Fortuin; B Pitt
Journal:  Circ Res       Date:  1971-02       Impact factor: 17.367

7.  On the nature of protection by propranolol against myocardial necrosis after temporary coronary occlusion in dogs.

Authors:  K A Reimer; M M Rasmussen; R B Jennings
Journal:  Am J Cardiol       Date:  1976-03-31       Impact factor: 2.778

8.  The influence of reperfusin on infarct size after experimental coronary artery occlusion.

Authors:  M Hofmann; M Hofmann; K Genth; W Schaper
Journal:  Basic Res Cardiol       Date:  1980 Jul-Aug       Impact factor: 17.165

9.  Experimental coronary artery occlusion. I. Measurement of infarct size.

Authors:  W Schaper; H Frenzel; W Hort
Journal:  Basic Res Cardiol       Date:  1979 Jan-Feb       Impact factor: 17.165

10.  Beneficial actions of N-dimethyl propranolol on myocardial oxygen balance and transmural perfusion gradients distal to a severe coronary artery stenosis in the canine heart.

Authors:  G J Gross; D C Warltier; H F Hardman
Journal:  Circulation       Date:  1978-10       Impact factor: 29.690

View more
  6 in total

1.  Determinants of infarct size in non-human primates.

Authors:  W Flameng; E Lesaffre; J Vanhaecke
Journal:  Basic Res Cardiol       Date:  1990 Jul-Aug       Impact factor: 17.165

2.  The effects of oral nafazatrom (= BAY g 6575) on canine coronary artery thrombosis and myocardial ischemia.

Authors:  V B Fiedler
Journal:  Basic Res Cardiol       Date:  1983 May-Jun       Impact factor: 17.165

3.  Infarct size in rabbits: a modified method illustrated by the effects of propranolol and trimetazidine.

Authors:  A J Drake-Holland; P R Belcher; J Hynd; M I Noble
Journal:  Basic Res Cardiol       Date:  1993 May-Jun       Impact factor: 17.165

4.  Effect of myocardial oxygen consumption on infarct size in experimental coronary artery occlusion.

Authors:  K D Müller; S Sass; M G Gottwik; W Schaper
Journal:  Basic Res Cardiol       Date:  1982 Mar-Apr       Impact factor: 17.165

5.  The inability of isoproterenol or propranolol to alter the lateral dimensions of experimentally induced myocardial infarcts.

Authors:  J M Downey; D Chambers; R D Wilkerson
Journal:  Basic Res Cardiol       Date:  1982 Sep-Oct       Impact factor: 17.165

6.  Comparison of various methods for assessing infarct-size in the dog.

Authors:  P A Martorana; H Göbel; B Kettenbach; R E Nitz
Journal:  Basic Res Cardiol       Date:  1982 May-Jun       Impact factor: 17.165

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.